2016
DOI: 10.1016/j.phytochem.2016.02.012
|View full text |Cite
|
Sign up to set email alerts
|

Quorum sensing inhibitory potential and molecular docking studies of sesquiterpene lactones from Vernonia blumeoides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
33
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(33 citation statements)
references
References 31 publications
0
33
0
Order By: Relevance
“…For instance, some terpenoids inhibit: (i) the morphogenesis, adhesion, and biofilm formation in Candida albicans as the example of linalool and farnesol [39]; (ii) the biofilm formation and elastase production in P. aeruginosa and Staphylococcus aureus as the example of viridiflorol, ursolic and betulinic acids [40]; or (iii) the production of native auto-inducers acylhomoserine lactones in P. aeruginosa [41] and the QS-controlled violacein production in C. violaceum as the example of the sesquiterpene lactones derivatives [42]. …”
Section: Discussionmentioning
confidence: 99%
“…For instance, some terpenoids inhibit: (i) the morphogenesis, adhesion, and biofilm formation in Candida albicans as the example of linalool and farnesol [39]; (ii) the biofilm formation and elastase production in P. aeruginosa and Staphylococcus aureus as the example of viridiflorol, ursolic and betulinic acids [40]; or (iii) the production of native auto-inducers acylhomoserine lactones in P. aeruginosa [41] and the QS-controlled violacein production in C. violaceum as the example of the sesquiterpene lactones derivatives [42]. …”
Section: Discussionmentioning
confidence: 99%
“…CviR is a LuxR receptor protein in C. violaceum ATCC 12472 which is activated by N‐hexanoyl homoserine lactone (C10‐AHL) produced by CviI. Antagonist molecules can bind in place of the natural AHL ligand, inducing the change of CviR conformation to inhibit the DNA binding of CviR and shut down the transcription of CviI and violacein biosynthetical genes . In the present study, we found the treatment of C. violaceum ATCC 12472 with 0.27 mM of compound 10 l consistently down‐regulated CviI and CviR compared to the untreated control.…”
Section: Potential CVI Protein‐compound 10 L Interactionsmentioning
confidence: 63%
“…Numerous medicinal plants have been exploited as effective medicines in the fight against drug resistant bacteria [2]. Plant constituents such as essential oils, terpenoids and sesquiterpenoids have been evaluated as potent antibacterial agents on resistant bacteria using novel molecular targets such as inhibitions of efflux pump [3] and quorum sensing [4]. However, drug combination has evolved as a novel strategy to fight resistant bacteria.…”
Section: Introductionmentioning
confidence: 99%